30243Q0
Transfusion Central Vein to Autologous with White Cells, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 3 Administration |
| Body System | 0 Circulatory |
| Operation | 2 Transfusion |
| Body Part | 4 Central Vein |
| Approach | 3 Percutaneous |
| Device | Q White Cells |
| Qualifier | 0 Autologous |
Operation Definition
Putting in blood or blood products
Procedure Overview
Transfusion is the administration of blood or a blood-derived product directly into a patient's circulation, most commonly packed red blood cells, platelets, fresh frozen plasma, or cryoprecipitate. It is used to treat significant blood loss, severe anemia, clotting disorders, or shortages of specific blood components caused by disease or treatment such as chemotherapy.
For a patient, a transfusion means receiving donated or, less commonly, their own previously collected blood through an intravenous line. The goal is to quickly restore oxygen-carrying capacity, clotting ability, or blood volume when the body cannot do so on its own. Transfusions are generally short procedures performed at the bedside, though the underlying condition prompting them can range from routine surgical blood loss to a life-threatening hemorrhage.
Anatomy & Axis Detail
Central Vein
A central vein, typically accessed via a catheter placed in the subclavian, internal jugular, or femoral vein with its tip terminating near the heart, provides high-flow access suited to rapid or large-volume blood product administration. Central venous transfusion is chosen when peripheral veins are inadequate, when massive transfusion protocols demand fast delivery, or when a patient already has central access for other therapy such as chemotherapy or dialysis. Because the catheter tip sits in a high-flow vessel, it tolerates viscous products like packed red cells or platelets with less risk of infiltration than a peripheral line, though it carries greater risk of catheter-related bloodstream infection. Documentation should identify the substance given and confirm the central location of the access device, distinguishing this route from peripheral vein transfusion for coding purposes.
Approach: Percutaneous
In Administration, Percutaneous denotes a substance delivered by needle injection through the skin, such as an intramuscular or subcutaneous injection, without cutting or scope guidance. It differs from External, where the substance is applied to the skin surface itself, and from Via Natural or Artificial Opening, where it is introduced through an orifice rather than through a puncture.
Substance: White Cells
White Cells designates a transfusion of granulocytes, most often neutrophils, given to patients with severe neutropenia and life-threatening infection who are not responding to antimicrobial therapy alone. It is a distinct blood component from Red Blood Cells and Platelets, targeting immune defense rather than oxygen delivery or hemostasis, and is comparatively uncommon due to donor collection demands and short product viability.
Qualifier: Autologous
This Administration qualifier indicates that the substance given, typically blood or blood products, came from the patient's own body, as in autologous blood transfusion using previously collected self-donated units. It distinguishes the source of the product from nonautologous transfusions, which use blood or tissue collected from another individual.
Coding & Documentation
Assigning a code from this family depends on documentation specifying the exact blood product given, whether it was autologous or from a donor, and the vessel or route used for infusion, such as a peripheral vein or central venous catheter. Nursing and physician notes recording units transfused, product type, and any reaction are the primary support for the code. A recurring error is selecting the wrong substance qualifier, for example coding platelets when frozen plasma was actually given, or overlooking that autologous blood requires a different qualifier than banked donor blood. Coders should also confirm the route matches what is documented rather than defaulting to peripheral vein.